Intervention
Whey protein, leucine and vitamin D formulation (PROVIDE protocol)
Research Observatory
Evidence Update
Current evidence
In PROVIDE, a supplement combining whey protein, leucine and vitamin D was compared with an equal-calorie control product in older adults with low muscle mass and reduced physical performance. The main grip-strength and overall physical-performance outcomes did not improve more with the supplement. Small improvements in muscle mass and chair-stand time were secondary findings; they do not establish disability prevention or a benefit from any single ingredient.
What changed
PROVIDE had null between-group primary grip/SPPB results, with small favorable secondary muscle-mass and chair-stand findings.
How to read these findings
SPPB is the Short Physical Performance Battery, a set of physical-performance tests. The main grip-strength and performance comparisons did not show an advantage.
Secondary outcomes are additional questions. Testing many outcomes increases the need for caution about favourable individual findings. This combined formulation cannot isolate the effect of vitamin D, leucine or whey protein.
Accepted limitations and study details
Exact reviewed qualifications are retained below. These details do not add a new accepted claim.
Study interpretation and limitations
- Primary nulls govern the verdict; short duration, multiplicity and combined formulation prevent an isolated vitamin-D or disability-prevention claim.
- Design: Randomized double-blind controlled trial
- Safety: Abstract is not an adequate full safety account; no broad tolerability claim.
- Interpretation: Secondary chair stand/mass cannot turn primary grip/SPPB null into success.
Why it matters
These findings apply to the studied populations, regimens and outcomes; they do not establish generalized longevity benefit.
Next proof
Longer function/disability-powered trial and full regimen/safety verification.